INTERCEPT PHARMACEUTICALS IN (ICPT) Stock Income Statement
USA - NASDAQ:ICPT - US45845P1084 - Common Stock
19 USD
+0.04 (+0.21%)
19 USD
0 (0%)
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 317.68M | 285.71M | 260.75M | 312.70M | 252.00M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 632.00K | 984.00K | 1.21M | 5.30M | 4.20M | |||
| Gross Profit | 317.05M | 284.73M | 259.55M | 307.40M | 247.80M | |||
| Operating Expenses | 372.15M | 352.94M | 360.24M | 526.00M | 560.20M | |||
| Research and Development | 160.42M | 176.64M | 182.75M | 191.50M | 242.80M | |||
| Selling, General, and Administrative Expenses | 211.73M | 176.30M | 177.49M | 334.50M | 317.40M | |||
| Operating Income | -55.09M | -68.22M | -100.69M | -218.60M | -312.40M | |||
| Interest Income/Expense | -10.23M | -21.39M | -54.42M | -48.10M | -41.10M | |||
| Other Income/Expense | 14.16M | 6.52M | 1.96M | 4.40M | 8.90M | |||
| Non Recurring Items | null | -91.78M | 16.80M | -12.60M | null | |||
| Income Before Taxes | -57.47M | -174.86M | -136.35M | -274.90M | -344.70M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -61.61M | 221.82M | -91.43M | -274.90M | -344.70M | |||
| EBITDA | -54.72M | -67.62M | -97.88M | -215.48M | -308.74M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.47073 | 6.55 | -2.86 | -8.34 | -10.89 | |||
| Non GAAP EPS | -1.33 | 6.04 | -3.41 | -7.970000000000001 | -10.889999999999999 | |||
| Statistics | ||||||||
| Gross Profit Margin | 99.80% | 99.66% | 99.54% | 98.31% | 98.33% | |||
| Profit Margin | -19.39% | 77.64% | -35.06% | -87.91% | -136.79% | |||
| Operating Profit Margin | -17.34% | -23.88% | -38.62% | -69.91% | -123.97% | |||
All data in USD